Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
The Lancet Gastroenterology & Hepatology in conversation with - Un podcast de The Lancet Group
Catégories:
Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedi...
